Eisai Co., Ltd. (ESAIY)
7.58
-0.19
(-2.45%)
USD |
OTCM |
Aug 24, 16:00
Eisai Net Income (Quarterly) : 120.18M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 120.18M |
| March 31, 2026 | -20.36M |
| December 31, 2025 | 115.82M |
| September 30, 2025 | 71.45M |
| June 30, 2025 | 106.09M |
| March 31, 2025 | 3.976M |
| December 31, 2024 | 160.05M |
| September 30, 2024 | 77.43M |
| June 30, 2024 | 73.86M |
| March 31, 2024 | 87.45M |
| December 31, 2023 | 44.83M |
| September 30, 2023 | 22.61M |
| June 30, 2023 | 151.97M |
| March 31, 2023 | 120.18M |
| December 31, 2022 | 64.51M |
| September 30, 2022 | 27.70M |
| June 30, 2022 | 215.42M |
| March 31, 2022 | -119.26M |
| December 31, 2021 | 114.61M |
| September 30, 2021 | 37.67M |
| June 30, 2021 | 386.71M |
| March 31, 2021 | -31.76M |
| December 31, 2020 | 188.83M |
| September 30, 2020 | 12.91M |
| June 30, 2020 | 230.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 445.82M |
| December 31, 2019 | 427.97M |
| September 30, 2019 | 49.05M |
| June 30, 2019 | 201.01M |
| March 31, 2019 | 206.52M |
| December 31, 2018 | 65.67M |
| September 30, 2018 | 185.14M |
| June 30, 2018 | 143.75M |
| March 31, 2018 | 219.43M |
| December 31, 2017 | 91.26M |
| September 30, 2017 | 88.16M |
| June 30, 2017 | 95.16M |
| March 31, 2017 | 11.54M |
| December 31, 2016 | 103.72M |
| September 30, 2016 | 84.65M |
| June 30, 2016 | 193.79M |
| March 31, 2016 | 144.30M |
| December 31, 2015 | 224.88M |
| September 30, 2015 | 46.16M |
| June 30, 2015 | 45.26M |
| March 31, 2015 | 55.51M |
| December 31, 2014 | 225.39M |
| September 30, 2014 | 45.36M |
| June 30, 2014 | 56.32M |
| March 31, 2014 | 34.09M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
| Santen Pharmaceutical Co., Ltd. | 45.18M |
| Ono Pharmaceutical Co., Ltd. | 151.63M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.471B |
| Total Expenses (Quarterly) | 1.356B |
| EPS Diluted (Quarterly) | 0.1015 |
| Enterprise Value | 8.479B |
| Gross Profit Margin (Quarterly) | 78.20% |
| Profit Margin (Quarterly) | 8.17% |
| Earnings Yield | 3.20% |
| Operating Earnings Yield | 3.32% |
| Normalized Earnings Yield | 3.206 |